Topical treatment with thiazolidinediones, activators of peroxisome proliferator-activated receptor-γ, normalizes epidermal homeostasis in a murine hyperproliferative disease model

Experimental Dermatology

Volumn 15, Issue 3, 2006, Pages 154-160

  Demerjian, Marianne ^a   Man, Mao Qiang ^a   Choi, Eung Ho ^a   Brown, Barbara E ^a   Crumrine, Debra ^a   Chang, Sandra ^a   Mauro, Theodora ^a   Elias, Peter M ^a   Feingold, Kenneth R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Epidermal thickness; Keratinocyte hyperproliferation; Nuclear hormone receptor; PPAR; Thiazolidinediones

Indexed keywords

ANTIPSORIASIS AGENT; BROXURIDINE; CIGLITAZONE; CYCLINE; FILAGGRIN; INVOLUCRIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; THYMIDINE; TROGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG INDICATION; EPIDERMIS HYPERPLASIA; FEMALE; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALE; METABOLIC REGULATION; MITOSIS INHIBITION; MOUSE; NICK END LABELING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; PSORIASIS; SKINFOLD THICKNESS;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; EPIDERMIS; FEMALE; KERATINOCYTES; MALE; MICE; PPAR GAMMA; THIAZOLIDINEDIONES;

EID: 33645902864     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2006.00402.x     Document Type: Article

References (24)

1. Bernerd F, Magnaldo T, Darmon M. Delayed onset of epidermal differentiation in psoriasis. J Invest Dermatol 1992: 98 (3): 902-910.
2. Gniadecki R. Regulation of keratinocyte proliferation (Review). Gen Pharmacol 1998: 30 (5): 619-622.
3. Jensen J M, Folster-Holst R, Baranowsky A et al. Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis. J Invest Dermatol 2004: 122 (6): 1423-1431.
4. Seguchi T, Cui C Y, Kusuda S, Takahashi M, Aisu K, Tezuka T. Decreased expression of filaggrin in atopic skin. Arch Dermatol Res 1996: 288 (8): 442-446.
5. Le T K, van der Valk P G, Schalkwijk J, van de Kerkhof P C. Changes in epidermal proliferation and differentiation in allergic and irritant contact dermatitis reactions. Br J Dermatol 1995: 133 (2): 236-240.
6. Denda M, Wood L C, Emami S et al. The epidermal hyperplasia associated with repeated barrier disruption by acetone treatment or tape stripping cannot be attributed to increased water loss. Arch Dermatol Res 1996: 288: 230-238.
7. Komuves L G, Hanley K, Man M Q et al. Keratinocyte differentiation in hyperproliferative epidermis: Topical application of PPARα activators restores tissue homeostasis. J Invest Dermatol 2000: 115 (3): 361-367.
8. Yki-Jarvinen H. Thiazolidinediones. N Engl J Med 2004: 351 (11): 1106-1118.
9. Barak Y, Nelson M C, Ong E S et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 1999: 4: 585-595.
10. Chawla A, Barak Y, Nagy L et al. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat Med 2001: 7 (1): 48-52.
11. Mangelsdorf D J, Thummel C, Beator M et al. The nuclear receptor superfamily, the second decade. Cell 1995: 83: 835-839.
12. Kuenzli S, Saurat J H. Peroxisome proliferator-activated receptors in cutaneous biology. Br J Dermatol 2003: 149: 229-236.
13. Westergaard M, Henningsen J, Johansen C et al. Expression and localization of peroxisome proliferators-activated receptors and nuclear factor κB in normal and lesional psoriatic skin. J Invest Dermatol 2003: 121 (5): 1104-1117.
14. Wahli W. Peroxisome proliferator-activated receptors (PPARS): From metabolic control to epidermal wound healing. Swiss Med Wkly 2002: 132: 83-91.
15. Rivier M, Safonova I, Lebrun P, Griffiths C E, Ailhaud G, Michel S. Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. J Invest Dermatol 1998: 111 (6): 1116-1121.
16. Rosenfield R L, Deplewski D, Greene M E. Peroxisome proliferator-activated receptors and skin development. Horm Res 2000: 54 (5-6): 269-274.
17. Man M Q, Fowler A J, Schmuth M, Lau P et al. Peroxisome-proliferator-activated receptor (PPAR)-gamma activation stimulates keratinocyte differentiation. J Invest Dermatol 2004: 123 (2): 305-312.
18. Ellis C N, Varani J, Fisher G J et al. Troglitazone improves psoriasis and normalizes models of proliferative skin disease: Ligands for peroxisome proliferators-activated receptor-gamma inhibit keratinocyte proliferation. Arch Dermatol 2000: 136 (5): 609-616.
19. Kuenzli S, Saurat J H. Effect of topical PPARbeta/delta and PPAR gamma agonists on plaque psoriasis. A pilot study. Dermatology 2003: 206 (3): 252 -256.
20. Elias P M, Choi E H. Interactions among stratum corneum defensive functions. Exp Dermatol 2005: 14: 719-726.
21. Connolly K M, Bogdanffy M S. Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: A dual-stain comparison with 5-bromo-2′-deoxyuridine. J Histochem Cytochem 1993: 41 (1): 1-6.
22. Komuves L G, Hanley K, Lefebvre A-M et al. Stimulation of PPARα promotes epidermal keratinocyte differentiation in vivo. J Invest Dermatol 2000: 115 (3): 353-360.
23. Komuves L G, Schmuth M, Fowler A J et al. Oxysterol stimulation of epidermal differentiation is mediated by liver X receptor-beta in murine epidermis. J Invest Dermatol 2002: 118 (1): 25-34.
24. Schmuth M, Haqq C M, Cairns W J et al. Peroxisome proliferator-activated receptor (PPAR)-b/d stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol 2004: 122 (4): 971-983.